CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-07 | PREVOZNIK MICHAEL E SVP & General Counsel | Shares withheld for taxes | −5,316 | $130.09 | $692K | 45,452 |
| 2022-03-07 | GUINAN MARK Executive Vice President & CFO | Grant or award | +20,780 | $130.09 | $2.7M | 109,456 |
| 2022-03-07 | GUINAN MARK Executive Vice President & CFO | Shares withheld for taxes | −10,475 | $130.09 | $1.4M | 98,981 |
| 2022-03-07 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award | +16,162 | $130.09 | $2.1M | 56,338 |
| 2022-03-07 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −7,947 | $130.09 | $1.0M | 48,391 |
| 2022-03-07 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award | +13,392 | $130.09 | $1.7M | 81,125 |
| 2022-03-07 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Shares withheld for taxes | −6,360 | $130.09 | $827K | 74,765 |
| 2022-03-07 | Davis J. E. EVP-Gen. Diagnostics/CEO Elect | Grant or award | +19,856 | $130.09 | $2.6M | 77,138 |
| 2022-03-07 | Davis J. E. EVP-Gen. Diagnostics/CEO Elect | Shares withheld for taxes | −10,330 | $130.09 | $1.3M | 66,808 |
| 2022-02-28 | PREVOZNIK MICHAEL E SVP & General Counsel | Sale | −661 | $130.00 | $86K | 39,224 |
| 2022-02-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Grant or award | +22,510 | 297,219 | ||
| 2022-02-24 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Grant or award · Non-Qualifed Stock Option (right to buy) | +109,317 | 109,317 | ||
| 2022-02-24 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Sale | −2,750 | $126.26 | $347K | 64,405 |
| 2022-02-24 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award | +3,328 | 67,733 | ||
| 2022-02-24 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award · Non-Qualifed Stock Option (right to buy) | +16,155 | 16,155 | ||
| 2022-02-24 | Davis J. E. EVP-Gen. Diagnostics/CEO Elect | Grant or award | +9,787 | 57,282 | ||
| 2022-02-24 | Davis J. E. EVP-Gen. Diagnostics/CEO Elect | Grant or award · Non-Qualifed Stock Option (right to buy) | +47,529 | 47,529 | ||
| 2022-02-24 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +549 | 27,276 | ||
| 2022-02-24 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +3,132 | 30,408 | ||
| 2022-02-24 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award · Non-Qualifed Stock Option (right to buy) | +2,654 | 2,654 |
Page 32 of 42 · 826 trades